Suppr超能文献

千禧年营养 N,N-二甲基甘氨酸(DMG)及其在自闭症谱系障碍中的功效。

Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders.

机构信息

Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.

Department of Microbiology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.

出版信息

Curr Med Chem. 2022;29(15):2632-2651. doi: 10.2174/0929867328666211125091811.

Abstract

Autism is a neurodevelopmental disorder belonging to the autism spectrum disorder (ASD). In ASDs, the individuals show substantial impairments in social communication, repetitive behaviours, and sensory behaviours deficits in the early stages of their life. Globally, the prevalence of autism is estimated to be less than 1%, especially in high- -income countries. In recent decades, there has been a drastic increase in the incidence of ASD, which has put ASD into the category of epidemics. Presently, two US Food and Drug Administration-approved drugs, aripiprazole and risperidone, are used to treat symptoms of agitation and irritability in autistic children. However, to date, no medication has been found to treat the core symptoms of ASD. The adverse side effects of conventional medicine and limited treatment options have led families of autistic children to turn to complementary and alternative medicine (CAM) treatments, which are perceived as relatively safe compared to conventional medicine. Recently N, N-dimethylglycine (DMG), a dietary supplement, has emerged as a useful supplement to improve the mental and physical state of children with ASD. The current review discusses ASD, the prevalence of ASD, the CAM approach, and the efficacy of CAM treatment in children with ASD. Moreover, it highlights the chemistry, pharmacological effect, and clinical studies of DMG, highlighting its potential for improving the lifestyle of children with ASD.

摘要

自闭症是一种神经发育障碍,属于自闭症谱系障碍(ASD)。在 ASD 中,个体在生命早期表现出社交沟通、重复行为和感官行为缺陷的明显障碍。在全球范围内,自闭症的患病率估计不到 1%,特别是在高收入国家。近几十年来,ASD 的发病率急剧上升,使 ASD 成为一种流行疾病。目前,两种获得美国食品和药物管理局批准的药物,阿立哌唑和利培酮,用于治疗自闭症儿童的激越和烦躁症状。然而,迄今为止,还没有发现药物可以治疗 ASD 的核心症状。传统药物的不良反应和有限的治疗选择导致自闭症儿童的家庭转向补充和替代医学(CAM)治疗,与传统药物相比,CAM 治疗被认为相对安全。最近,N,N-二甲基甘氨酸(DMG)作为膳食补充剂,已成为改善自闭症儿童精神和身体状态的有用补充剂。本文综述了 ASD、ASD 的流行率、CAM 方法以及 CAM 治疗 ASD 儿童的疗效。此外,还强调了 DMG 的化学、药理学作用和临床研究,突出了其改善 ASD 儿童生活方式的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验